Levetiracetam Altan

Levetiracetam, the active ingredient in Levetiracetam Altan, is an antiepileptic presented as an intravenous formulation for intravenous use. It is indicated for the treatment of partial‑onset seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients who require rapid or controlled drug delivery. The product complies with European Union regulatory standards and is manufactured under GMP conditions.

GNH USA supplies Levetiracetam Altan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam Altan is an antiepileptic drug used to control seizure activity across several seizure types.

Partial‑onset seizures: reduces frequency and severity of focal seizures. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: diminishes rapid, involuntary muscle jerks.

Levetiracetam Altan may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Fatigue: mild to moderate tiredness. - Dizziness: transient sensation of light‑headedness. - Headache: occasional throbbing pain. - Nausea: mild gastrointestinal upset. - Irritability: mood changes or agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Mood disorders: depression or suicidal thoughts. - Hematologic abnormalities: low blood cell counts. - Hepatic dysfunction: elevated liver enzymes. - Respiratory depression: especially when combined with other CNS depressants.

Before initiating therapy with Levetiracetam Altan, clinicians should consider several safety factors.

Renal impairment: adjust dosage or monitor plasma levels. Hepatic impairment: evaluate liver function regularly. Pregnancy: risk unknown; weigh benefits against potential fetal exposure. Concomitant CNS depressants: use with caution due to additive sedation. Behavioral changes: monitor for mood swings or aggression. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Levetiracetam Altan can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Strong enzyme inducers (phenytoin, phenobarbital): can lower drug levels. - Alcohol: increased risk of CNS depression.

Moderate Interactions (Monitor Closely): - Valproate: may increase adverse effect profile. - Antidepressants (SSRIs, SNRIs): watch for enhanced sedation. - Other antiepileptics (lamotrigine, topiramate): adjust monitoring as needed.